Skip to main content


Latest articles

25-06-2021 | Rheumatology | News | Article

Study supports importance of second COVID-19 vaccine dose in DMARD-treated RA patients

Rheumatoid arthritis patients are more likely than healthy controls to require both doses of vaccines against SARS-CoV-2 in order to mount an adequate immune response, researchers report.

24-06-2021 | Rheumatology | News | Article

DESIRES trial demonstrates promise for rituximab in systemic sclerosis

Findings from the DESIRES trial suggest that patients with systemic sclerosis derive significant improvements in skin sclerosis and lung function from treatment with rituximab.

23-06-2021 | Rheumatology | News | Article

‘Significant humoral response’ following two COVID-19 vaccine doses in RMD patients

Most patients with rheumatic and musculoskeletal diseases mount a humoral immune response following receipt of the second dose of the Pfizer–BioNTech vaccine against SARS-CoV-2, say researchers.

22-06-2021 | Rheumatology | News | Article

NSAID use, limited physical activity linked to knee OA progression risk

Using nonsteroidal anti-inflammatory drugs and not meeting physical activity guidelines are both modifiable clinical risk factors for radiographic progression among people with knee osteoarthritis, say researchers.

21-06-2021 | Rheumatology | News | Article

Studies evaluate effectiveness of IVIG, glucocorticoids for MIS-C

Two real-world studies published in The New England Journal of Medicine draw conflicting conclusions on the effectiveness of treatment regimens involving intravenous immunoglobulin and glucocorticoids for the treatment of multisystem inflammatory disease in children.

18-06-2021 | Rheumatology | News | Article

IL-17A inhibitors supported for axSpA in the UK

Click through for more information on these two NICE recommendations

16-06-2021 | Rheumatology | News | Article

Tofacitinib beneficial for COVID-19 pneumonia

Add-on treatment with the JAK inhibitor tofacitinib reduces the risk for death or respiratory failure among hospitalized patients with COVID-19 pneumonia who are not receiving mechanical ventilation, shows the STOP-COVID trial.

16-06-2021 | Rheumatology | News | Article

Biomarkers may distinguish hyperinflammatory syndromes in children

Two studies have identified serum biomarkers that could be used to differentiate between hyperinflammatory syndromes in children.

15-06-2021 | Rheumatology | News | Article

ACR issues guidelines for rheumatoid arthritis treatment

Click through for more information on the recommendations

14-06-2021 | Rheumatology | News | Article

Osteoarthritis linked to elevated risk for Parkinson’s disease

People with osteoarthritis have a significantly higher long-term risk for developing Parkinson’s disease than those without, researchers report.

11-06-2021 | Rheumatology | News | Article

COVID-19 antibody data reassuring for people with SLE

The majority of patients with systemic lupus erythematosus and confirmed COVID-19 are able to produce a durable antibody response to the infection, despite the use of immunosuppressants, US research suggests.

10-06-2021 | Rheumatology | News | Article

Inflammation not accurately reflected by tender joints in RA

Tender joints in patients with rheumatoid arthritis may not be a suitable indicator of inflammation, study findings show.

09-06-2021 | Rheumatology | News | Article

Home-based biologic infusions may increase risk for AEs requiring care escalation

Home-administered biologic infusions are associated with higher risks for postinfusion emergency department visits or hospital admission and treatment discontinuation compared with facility-administered infusions, real-world data show.

08-06-2021 | Rheumatology | News | Article

​​​​​​​EULAR issues recommendations on intra-articular therapies

EULAR has developed evidence-based recommendations on the use of intra-articular therapy in adult patients with peripheral arthropathies.

07-06-2021 | Rheumatology | News | Article

Upadacitinib beneficial in PsA patients with axial involvement

A pooled analysis of data from the SELECT-PsA-1 and SELECT-PsA-2 trials suggests that treatment with the JAK inhibitor upadacitinib improves axial symptoms in patients with psoriatic spondylitis.

07-06-2021 | Rheumatology | News | Article

BIOCOV study supports rituximab link to severe COVID-19

Further research confirming an association between rituximab and an increased risk for severe COVID-19 was reported at the EULAR 2021 Virtual Congress.

07-06-2021 | Rheumatology | News | Article

Real-world studies point to similar effectiveness of JAK inhibitors and biologics

Findings from two real-world studies presented at the EULAR 2021 Virtual Congress suggest that JAK inhibitors and biologics are similarly effective for the treatment of inflammatory arthritis.

06-06-2021 | Rheumatology | News | Article

​​​​​​​Genetic study points to causal link between gout and hypertension

A Mendelian randomization analysis presented at the EULAR 2021 Virtual Congress suggests that the association between gout and hypertension may have a causal basis.

06-06-2021 | Rheumatology | News | Article

Mavrilimumab shows potential for severe COVID-19

Inhibition of GM-CSF with mavrilimumab may represent a promising treatment option for patients with severe COVID-19 pneumonia and systemic hyperinflammation, suggest phase 2 study results.

05-06-2021 | Rheumatology | News | Article

Pfizer–BioNTech vaccine immunogenicity confirmed in patients with AIIRDs

Research confirms immunogenicity with the Pfizer–BioNTech COVID-19 vaccine in most patients with autoimmune inflammatory rheumatic diseases.

Image Credits